From Awareness to Action—Tackling AMR together

From Awareness to Action-Tackling AMR togetherAntimicrobial resistance (AMR) is one of the most serious health threats facing humanity.It could cause 10 million deaths per year and an overall cost of $100 trillion to the global economy by 2050.According to The World Health Organization, antibiotic resistance is one of the biggest threats to global health today.It occurs when bacteria changes in response to the use of antibiotics.While this happens naturally, the overuse and misuse of antibiotics have accelerated the process, leading to record high levels of antibiotic resistance.It is rising to dangerously high levels in all parts of the world and compromising our ability to treat infectious diseases.Global AMR burden-4.71 million deaths were associated with bacterial AMR in 2021, with 1.14 million directly attributable to resistant bacterial infections.Over the past three decades (between 1990 and 2021), there have been significant shifts in AMR-related mortality patterns.While AMR-related deaths among children under five declined by over 50%-thanks to improvements in infection prevention and vaccination-deaths in adults aged 70 and older increased by >80%, largely due to aging populations and their increased susceptibility to infections.Global trends indicate that resistance to key pathogens is rising, with methicillin-resistant Staphylococcus aureus (MRSA) attributable deaths more than doubling from 57,200 in 1990 to 1,30,000 in 2021.Resistance to carbapenems among Gram-negative bacteria also surged, contributing to over 1 million deaths associated with carbapenem-resistant infections in 2021.The major drivers of AMR and AMR-related mortality include the overuse of antibiotics in human health and agriculture, limited access to effective antibiotics in resource-limited settings, and insufficient investment in antimicrobial stewardship programs.World Antimicrobial Awareness Week is held annually from November 18 to 24 to raise awareness about AMR.The week serves to promote best practices to prevent the emergence and spread of AMR in human, animal, and environmental health by encouraging education, advocacy, and concrete actions from the public, health workers, and policymakers.It encourages all sectors to use antimicrobials prudently, to work together and to strengthen preventive measures addressing AMR.It is a global campaign that is celebrated annually to improve awareness and understanding of AMR and encourage best practices among the public, One Health stakeholders and policymakers, who all play a critical role in reducing the further emergence and spread of AMR.The week encourages global communities to educate themselves and others about AMR.It serves as a call to action for individuals, health professionals, and policymakers to advocate for stronger leadership and more concrete commitments to combat AMR.Activities like best practices in using antimicrobials responsibly, preventing infections, and implementing antimicrobial stewardship are promoted.The theme for WAAW 2025 is "Act Now: Protect Our Present, Secure Our Future."Surveillance systems play a pivotal role in mitigating the AMR crisis by enabling the early detection of resistance patterns, assessing the effectiveness of interventions, and also by shaping treatment guidelines.Number of new antibiotics discovered in last 50 years is very limited.There are many challenges in the antibiotic pipeline.Complex and lengthy process of antimicrobial drug development, from initial discovery to regulatory approval is a major hurdle.Key bottlenecks, including high costs, prolonged research timelines, regulatory challenges and the lack of financial incentives for pharmaceutical companies, with important implications in the future for availability and affordability within the WHO's AWARE framework (Access, Watch and Reserve antibiotic categories).The urgent need for scientific innovation and interdisciplinary collaboration to revitalize the antibiotic development pipeline is evident.We should explore global policy frameworks and the need for equity-driven AMR interventions like developing infrastructure for AMR detection, implementing infection control measures, and ensuring judicious antibiotic use.While the WHO provides a framework for national action plans on AMR, there are challenges of implementing AMR policies in low-and middle-income countries (LMICs), like need for evidence-based, cost-effective, and locally adapted policies.Multi-stakeholder engagement and community-driven initiatives are advocated to ensure successful implementation.Engaging local communities is crucial, as public awareness and behavioral changes in antibiotic use are key components of AMR mitigation.There is an urgent need for global action, including strengthening AMR surveillance systems, investing in diagnostic innovation, accelerating antibiotic development, and also ensuring equitable policy implementation.Such efforts have to be seen as essential to curbing the spread of resistant pathogens and sustaining the effectiveness of existing antimicrobial treatments.A coordinated, multi-sectoral approach is essential to addressing AMR -bringing together governments, scientists, industry leaders and civil society.Without decisive action, AMR will continue to threaten global health security and modern medicine.There are also ramifications beyond health consequences, as AMR has significant socioeconomic implications (particularly for LMICs), with concomitant loss of productivity, increased poverty levels and a widening global health disparity.The fight against AMR demands scientific excellence, education, advocacy and immediate interventions.Strengthening surveillance, ensuring equitable access to quality medicines and diagnostics, fostering innovation and building resilient systems all require long-term commitment and resources.Investment in AMR action is a smart move for a safer, healthier future.Whether it's a hospital administrator setting up an antimicrobial stewardship team or a farmer adopting sustainable waste